Viracta Therapeutics Inc (VIRX)
0.2003
0.00 (0.00%)
USD |
NASDAQ |
Nov 05, 16:00
0.2003
0.00 (0.00%)
After-Hours: 16:12
Viracta Therapeutics Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Biomarin Pharmaceutical Inc | 0.1098 |
| Arbutus Biopharma Corp | 0.00 |
| GlycoMimetics Inc | -- |
| FibroGen Inc | -0.3119 |
| Cidara Therapeutics Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 31.32M |
| Total Liabilities (Quarterly) | 28.65M |
| Shareholders Equity (Quarterly) | 2.671M |